Hepatitis B virus surface antigen mutants persist in chronic carriers receiving lamivudine therapy in Singapore.
Chen
Wei Ning
WN
Oon
Chong Jin
CJ
Lim
Gek Keow
GK
D002353:Carrier State / Q000188:drug therapy* / Q000821:virology*; D006514:Hepatitis B Surface Antigens / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D009154:Mutation / Q000187:drug effects; D012846:Singapore
D006514:Hepatitis B Surface Antigens; D019259:Lamivudine